PT  - JOURNAL ARTICLE
AU  - Sandhya Khurana
AU  - Andrew Bush
AU  - Fernando Holguin
ED  - ,
TI  - Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report
AID  - 10.1183/20734735.0058-2020
DP  - 2020 Jun 01
TA  - Breathe
PG  - 200058
VI  - 16
IP  - 2
4099  - http://breathe.ersjournals.com/content/16/2/200058.short
4100  - http://breathe.ersjournals.com/content/16/2/200058.full
SO  - Breathe2020 Jun 01; 16
AB  - Educational aimsThis article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists.It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.This article summarises the 2019 @EuroRespSoc/@ATScommunity Severe Asthma Task Force recommendations on the use of anti-IL-5 strategy, anti-IL-4/13 antibody, tiotropium and macrolides in severe asthma, and the role of biomarkers in directing therapy https://bit.ly/3braK43